DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Issue 10 · Volume 47 · September 2015 DOI: 10.1055/s-005-30121 Autoimmune Thyroid Diseases

Erratum

  • e4
    Banga, J. P.; Moshkelgosha, S.; Berchner-Pfannschmidt, U.; Eckstein, A.:

    Modeling Graves’ Orbitopathy in Experimental Graves’ Disease

    • Editorial

  • 699
    Banga, J. P.; Schott, M.:

    Autoimmune Thyroid Diseases

    • Review

  • 702
    Ajjan, R. A.; Weetman, A. P.:

    The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding

  • 711
    Kong, Y. M.; Brown, N. K.; Morris, G. P.; Flynn, J. C.:

    The Essential Role of Circulating Thyroglobulin in Maintaining Dominance of Natural Regulatory T Cell Function to Prevent Autoimmune Thyroiditis

  • 721
    Duntas, L. H.:

    The Role of Iodine and Selenium in Autoimmune Thyroiditis

  • 727
    Morshed, S. A.; Davies, T. F.:

    Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies

  • 735
    Furmaniak, J.; Sanders, J.; Núñez Miguel, R.; Rees Smith, B.:

    Mechanisms of Action of TSHR Autoantibodies

  • 753
    Pujol-Borrell, R.; Giménez-Barcons, M.; Marín-Sánchez, A.; Colobran, R.:

    Genetics of Graves’ Disease: Special Focus on the Role of TSHR Gene

  • 767
    Piantanida, E.; Lai, A.; Sassi, L.; Gallo, D.; Spreafico, E.; Tanda, M. L.; Bartalena, L.:

    Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs

  • 773
    Bahn, R. S.:

    Current Insights into the Pathogenesis of Graves’ Ophthalmopathy

  • 779
    Salvi, M.; Campi, I.:

    Medical Treatment of Graves’ Orbitopathy

  • 789
    Neumann, S.; Place, R. F.; Krieger, C. C.; Gershengorn, M. C.:

    Future Prospects for the Treatment of Graves’ Hyperthyroidism and Eye Disease

  • 797
    Banga, J. P.; Moshkelgosha, S.; Berchner-Pfannschmidt, U.; Eckstein, A.:

    Modeling Graves’ Orbitopathy in Experimental Graves’ Disease